A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside other inflammatory conditions.

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

The IGFL2 gene encodes a cytokine found in primates, which are closely related to humans. In the joint tissue of people with rheumatoid arthritis, peripheral helper T (Tph) cells express IGFL2, which ...

While rheumatoid arthritis can affect adults of any age, it’s most commonly starts among people between the ages of 40 and 60 ...

Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...